Netherlands National Drug Monitor - Research and Documentation ...
Netherlands National Drug Monitor - Research and Documentation ...
Netherlands National Drug Monitor - Research and Documentation ...
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
together with another substance) was 14% in 2008 <strong>and</strong> 22% in the first half of<br />
2009. In 2007 <strong>and</strong> 2006 the numbers were 10% <strong>and</strong> 9% respectively.<br />
- In 2009, however, for the first time other pharmacologically active substances were<br />
found in Ecstasy tablets. These include 4-fluoramphetamine <strong>and</strong> mephedrone (see<br />
Other Substances).<br />
• The percentage of ‘Ecstasy pills’ containing no MDMA-like substance, but instead<br />
containing amphetamine or methamphetamine rose from 1.4% in 2008 to 4% in the<br />
first half of 2009.<br />
• The average amount of MDMA in Ecstasy pills rose from 74 mg in 2006 to 82 mg<br />
in 2007, stabilising at an average of 81 mg in 2008. In the first half of 2009 there<br />
was a sharp drop to 65 mg. The highest dosage measured in 2009 was 203 mg; this<br />
compares to 20 mg in 2008 <strong>and</strong> 199 mg in 2007.<br />
• Figure 5.6 shows that the proportion of high-dose Ecstasy pills (more than 105 mg<br />
MDMA) on average remained stable in 2007 <strong>and</strong> 2008 (30%). There was a sharp<br />
drop in this rate to 9% in the second quarter of 2009.<br />
• These trends suggest a reduced availability of MDMA in the second half of 2008 <strong>and</strong><br />
the first half of 2009.<br />
Table 5.8 Number <strong>and</strong> composition of (Ecstasy) tablets submitted to DIMS that were analysed in the<br />
lab, from 1999<br />
Total number of<br />
tablets analysed<br />
1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 IV<br />
1 805 2 462 2 359 2 130 2 177 1 985 2 134 2 523 2 319 2 185 I 1 140<br />
MDMA 83.7 87.6 86.1 84.9 85.4 85.6 76.0 75.4 78.8 69.5 52.2<br />
MDEA 1.6 0.8 0.7 0.4 0.5 0.1 0.3 0.2 0.4 0.2 0.3<br />
MDA 2.4 1.9 0.6 1.4 0.9 1.9 2.9 0.4 0.0 0.0 0.3<br />
MBDB 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0<br />
Combination of 1.0 2.7 2.5 1.5 2.2 4.4 5.2 0.8 0.9 0.9 3.1<br />
ces II<br />
Ecstasy-like substan-<br />
Combination of<br />
Ecstasy-like II <strong>and</strong> other<br />
pharmacologically<br />
active substance III 5.1 4.1 7.4 8.2 8.3 5.4 7.8 13.0 11.0 9.4 14.0<br />
(Meth)Amphetamine 3.0 0.7 0.7 1.7 1.0 0.3 3.9 0.9 0.4 0.5 1.8<br />
(Meth)amphetamine<br />
+ other<br />
Other pharmacologically<br />
active substance<br />
No pharmacologically<br />
active substance<br />
0.5 0.2 0.3 0.2 0.2 0.0 0.1 0.9 0.3 0.9 2.2<br />
2.2 1.4 1.1 0.8 0.6 1.7 3.2 7.1 7.3 15.3 24.6<br />
0.6 0.6 0.6 0.8 0.8 0.7 0.7 1.2 0.8 3.3 1.5<br />
Percentage of tablets containing a particular substance or combination of substances. Categories are mutually<br />
exclusive <strong>and</strong> add up to 100 percent. I. Total after correction. II. Ecstasy-like means MDMA, MDEA,<br />
MDA or MBDB . III. For instance, caffeine, paracetamol <strong>and</strong> mCPP. IV. Only the first six months of 2009.<br />
Source: DIMS.<br />
5 Ecstasy, amphetamine <strong>and</strong> related substances<br />
127